'

DFNS.net CBRN News Blog

0

UGA Wins Gates Foundation Grant to Study Norovirus

The University of Georgia College of Veterinary Medicine announced recently that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Ralph A. Tripp, a professor of...

0

Improved Mouse Model Will Accelerate Ebola Research

In the war against Ebola one important hurdle has just been cleared – by a mouse. Researchers at the University of North Carolina at Chapel Hill and colleagues have developed the first genetic strain...

0

NCT CBRNe USA – Call for Papers

IB Consultancy, in partnership with the National Consortium for the Study of Terrorism and Responses to Terrorism (START), has issued a call for papers to be presented at the Non-Conventional Threat (NCT) CBRNe USA...

0

Image (Video) of the Day: Zombie Modeling!

For those Geographical Information Science (GIS) and Agent-Based Modeling (ABM) wonks out there, you might appreciate Dr. Andrew Crooks’ simple agent-based model of zombie attack. Dr. Crooks, an Assistant Professor in the Department of...

0

DTRA Issues Ebola Broad Agency Announcement

GLOBAL BIODEFENSE – The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) has issued a new funding mechanism for advancing Ebola countermeasures during FY2015-2016. The primary objective of the Broad Agency...

0

Global Infection Outbreaks on the Rise

GLOBAL BIODEFENSE – Enterovirus. Tuberculosis. Cholera. Measles. Various strains of the flu and hepatitis. The number of infectious disease outbreaks and the number of unique illnesses causing them appear to be increasing around the...

0

Russia exercises its strategic nuclear ‘triad’

Since 28 October Moscow has tested and exercised all three components of its nuclear arsenal, including the firing of submarine-launched and land-based intercontinental ballistic missiles (SLBMs and ICBMs) as well as extensive long-range strategic...

0

Islamic State Goes Old School

By Erik Goepner Recent reports suggest that IS has employed chlorine as a weapon. Though currently unconfirmed, these reports suggest that IS is looking to bolster its inventory of tactics, techniques and procedures. In...

0

DHS Backs Scholarship Program for Biothreat Genomics

The University of Texas at San Antonio (UTSA) has been awarded a two-year, $400,000 grant from the Department of Homeland Security (DHS) to develop a DHS Scholars Program, aimed towards building a future workforce...

0

Russia boycotts nuclear summit planning meeting

USA TODAY / AP – Russia has failed to show up at a meeting planning the 2016 Nuclear Security Summit, U.S and European officials said Monday, in a potentially serious blow to efforts by...

0

The new HAZMAT Playbook

Alluviam’s HazMasterG3 Version 18 delivers exclusive HazMAT Quick Start best-practices playbook to responders, is endorsed by HazMatIQ and has been adopted for use in their HMEIQ training program for military and civilian hazardous materials...

0

Steris Corporation receives JSEW award

STERIS CORPORATION RECEIVES AWARD OF JOINT SERVICE EQUIPMENT WIPE (JSEW) DEPARTMENT OF DEFENSE CONTRACT …read more From:: CBRNe World (CBRN)

0

Battelle award $2m contract to Colorado State U

Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded $2 million by the U.S. Department of Defense (DoD) to aid in the development and manufacturing of a vaccine to protect...

0

Dew point

DEW Engineering to supply CBRN Decontaminating Systems to Canadian Armed Forces …read more From:: CBRNe World (CBRN)

0

Inhaled Ebola Vaccine Shows Promise in Pre-Clinical Study

A breathable vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. A vaccine which is inhalable could help overcome the logistical obstacles of storing, transporting...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close